We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$287M
AUM Growth
+$51.4M
Cap. Flow
+$28.9M
Cap. Flow %
10.07%
Top 10 Hldgs %
50.36%
Holding
177
New
21
Increased
16
Reduced
3
Closed
14

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$13.4M
2
QCOM icon
Qualcomm
QCOM
+$9.16M
3
CVX icon
Chevron
CVX
+$4.19M
4
TXT icon
Textron
TXT
+$3.78M
5
MU icon
Micron Technology
MU
+$3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.71M
2
DIS icon
Walt Disney
DIS
+$6.12M
3
OGN icon
Organon & Co
OGN
+$1.97M
4
SPHR icon
Sphere Entertainment
SPHR
+$1.39M
5
ESPR
Esperion Therapeutics
ESPR
+$1.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 40.64%
2 Healthcare 18.12%
3 Technology 12.55%
4 Materials 9.73%
5 Energy 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVNA icon
51
PUT
Carvana
CVNA
$45.8B
$987K 0.34%
15,000
– –
OSUR icon
52
OraSure Technologies
OSUR
$263M
$977K 0.34%
219,033
– –
EQX icon
53
Equinox Gold
EQX
$13.3B
$973K 0.34%
100,000
– –
SOXX icon
54
PUT
iShares Semiconductor ETF
SOXX
$48.3B
$961K 0.34%
+1,500
New +$762K
UBS icon
55
UBS Group
UBS
$149B
$942K 0.33%
19,000
– –
NOK icon
56
Nokia
NOK
$58B
$930K 0.32%
70,000
– –
BBD icon
57
Banco Bradesco
BBD
$35.6B
$917K 0.32%
264,336
– –
REPL icon
58
Replimune Group
REPL
$1.22B
$890K 0.31%
+80,400
New +$492K
ORCL icon
59
CALL
Oracle
ORCL
$418B
$879K 0.31%
6,000
– –
CLBT icon
60
Cellebrite
CLBT
$2.75B
$876K 0.31%
+60,000
New +$793K
ICLR icon
61
Icon
ICLR
$13.1B
$869K 0.3%
5,000
– –
SNY icon
62
Sanofi
SNY
$97.6B
$853K 0.3%
20,000
– –
BKR icon
63
Baker Hughes
BKR
$55.5B
$833K 0.29%
15,000
+10,000
+200% +$632K
DHC
64
Diversified Healthcare Trust
DHC
$1.92B
$791K 0.28%
85,000
– –
KGS icon
65
Kodiak Gas Services
KGS
$5.23B
$789K 0.28%
10,500
– –
LNTH icon
66
Lantheus
LNTH
$6.5B
$788K 0.27%
7,100
– –
MCD icon
67
CALL
McDonald's
MCD
$166B
$757K 0.26%
2,800
– –
BIIB icon
68
Biogen
BIIB
$33.6B
$756K 0.26%
3,500
– –
KSPI icon
69
Kaspi.kz JSC
KSPI
$18.2B
$754K 0.26%
8,700
– –
RGLD icon
70
Royal Gold
RGLD
$20.2B
$749K 0.26%
3,750
– –
RMR icon
71
The RMR Group
RMR
$313M
$729K 0.25%
35,500
– –
KBR icon
72
KBR
KBR
$4.43B
$691K 0.24%
+20,000
New +$697K
BKT icon
73
BlackRock Income Trust
BKT
$309M
$684K 0.24%
63,810
– –
ITUB icon
74
Itaú Unibanco
ITUB
$89.2B
$673K 0.23%
82,400
– –
VRT icon
75
CALL
Vertiv
VRT
$95.6B
$670K 0.23%
2,000
– –
1 2
3
4 5

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Pavaki Capital Management held 177 positions worth $287M, up 22% from $235M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $28.9M of net new capital in Q2 2026, opening 21 new positions and adding to 16 existing holdings. Its largest new stake was Intuit: 38,600 shares worth $10.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intel, an estimated $9.71M trimmed.

  • Pavaki Capital Management's largest Q2 2026 buy was Intuit: 38,600 shares worth $10.1M.
  • Pavaki Capital Management added most to Chevron in Q2 2026, an estimated $4.19M increase.
  • Pavaki Capital Management's biggest Q2 2026 reduction was Intel, cutting an estimated $9.71M.
  • Pavaki Capital Management fully exited Organon & Co in Q2 2026, selling an estimated $1.97M.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $287M portfolio in Q2 2026.
  • Pavaki Capital Management opened 21 new positions and closed 14 in Q2 2026.
  • Pavaki Capital Management's portfolio value rose 22% quarter-over-quarter to $287M.

Based on Pavaki Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.